The PE Ratio as of May 2025 (TTM) for Omeros Corporation (OMER) is -1.39

According to Omeros Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -1.39. This represents a change of -35.71% compared to the average of -2.16 of the last 4 quarters.

Omeros Corporation (OMER) Historical PE Ratio (quarterly & annually)

How has OMER PE Ratio performed in the past?

The mean historical PE Ratio of Omeros Corporation over the last ten years is -4.56. The current -1.39 PE Ratio has changed 2.95% with respect to the historical average. Over the past ten years (40 quarters), OMER's PE Ratio was at its highest in in the June 2022 quarter at 6.55. The PE Ratio was at its lowest in in the September 2017 quarter at -33.42.

Omeros Corporation (OMER) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Omeros Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Omeros Corporation (OMER) Average PE Ratio

How has OMER PE Ratio performed in the past?

The current PE Ratio of Omeros Corporation (OMER) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Omeros Corporation (OMER) PE Ratio vs. Peers

How is OMER’s PE Ratio compared to its peers?

Omeros Corporation’s PE Ratio is greater than Crinetics Pharmaceuticals, Inc. (-9.68), less than Enanta Pharmaceuticals, Inc. (-1.18), greater than Amicus Therapeutics, Inc. (-63.74), greater than Cerevel Therapeutics Holdings, Inc. (-17.73), greater than Connect Biopharma Holdings Limited (-2.80), greater than Ligand Pharmaceuticals Incorporated (-15.28), less than Passage Bio, Inc. (-0.30), greater than ORIC Pharmaceuticals, Inc. (-2.86), less than Lyell Immunopharma, Inc. (-0.32), greater than Design Therapeutics, Inc. (-4.02), greater than Revolution Medicines, Inc. (-10.97), greater than Akero Therapeutics, Inc. (-12.00), greater than Avidity Biosciences, Inc. (-11.52), less than Protagonist Therapeutics, Inc. (49.37), greater than Stoke Therapeutics, Inc. (-5.86), greater than Arcutis Biotherapeutics, Inc. (-13.49), greater than Icosavax, Inc. (-15.78), greater than Mirum Pharmaceuticals, Inc. (-28.62), greater than VectivBio Holding AG (-7.94), greater than Day One Biopharmaceuticals, Inc. (-9.27), less than Biomea Fusion, Inc. (-0.62), less than Homology Medicines, Inc. (-0.01), greater than Gossamer Bio, Inc. (-4.49),

Build a custom stock screener for Omeros Corporation (OMER) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Omeros Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Omeros Corporation (OMER) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Omeros Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.